AuraVax Therapeutics names new chief executive officer

Sensorion Appoints David Lawrence as Chief Financial Officer

OSE Immunotherapeutics announces approval from Spanish Drug Agency for early access program for Tedopi to treat metastatic non-small cell lung cancer

Dynavax Technologies' HEPLISAV B hepatitis drug receives British Marketing Authorisation

Agilent's xCELLigence RTCA HT Platform Now Integrates with the BioTek BioSpa 8 Automated Incubator

LinKinVax Touts Interim Results of the ANRS VRI06 Phase I Trial Evaluating a Novel HIV Vaccine Candidate

Sarlis Named CMO, Head of Clinical Development at Cleara Biotech

GenScript ProBio partners with RVAC Medicines

Bugworks Research adds Dr Renu Swarup as honorary member of the Global Advisory Board

US FDA Accepts Biologics License Application for Pfizer's Respiratory Syncytial Virus Maternal Vaccine Candidate for Priority Review

US FDA Accepts for Priority Review the Supplemental New Drug Application for US Merck's PREVYMIS for Prophylaxis of Cytomegalovirus Disease in Kidney Transplant Recipients at High Risk

Pfizer granted priority review of RSV vaccine candidate

WestVac Biopharma claims 'significant progress' in COVID-19 vaccine development against latest prevalent subvariants

Valneva's single-shot chikungunya vaccine candidate gets FDA priority review

Avilar Therapeutics Increases Financing to USD 75m to Advance Pipeline of Novel Extracellular Protein Degraders